Since 1993, OrbiMed has been an active investor in venture capital. Our team has helped to start, nurture and commercialize some of today's most successful health sciences companies. OrbiMed seeks to be the capital provider of choice to life sciences companies seeking growth and new opportunities. The following companies represent our current portfolio of private equity investments:

	Acceleron Pharma Developing therapeutics for metabolic and musculoskeletal diseases affecting millions of people  Learn more
	Adimab Fully integrated yeast-based antibody discovery, maturation and production  Learn more
	Affimed Discovering and developing next generation antibody therapies  Learn more
	Amarin Discovering and developing novel treatments for cardiovascular diseases  Learn more
	Ambit Biosciences Discovering and developing small-molecule kinase inhibitors for the treatment of cancer  Learn more
	Amnis Corporation Commercializing innovative cellular imaging technologies  Learn more
	Anthera Developing and commercializing products to treat serious illnesses, including cardiovascular and autoimmune diseases  Learn more
	Aragon Pharmaceuticals Developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers  Learn more
	Arsanis Biosciences Developing antibody therapeutics for infectious diseases for which current prophylactic or therapeutic approaches are ineffective or nonexistent  Learn more
	Athersys Developing and commercializing novel treatments for obesity, cognitive and attention/sleep disorders  Learn more
	Bharat Serums and Vaccines, Ltd. Developing and manufacturing a wide range of products such as plasma derivatives, hormones, antifungals, anaesthetics, cardiovascular and diagnostic products  Learn more
	Biodel Inc. Developing innovative treatments for diabetes  Learn more
	Biolex Developing improved biologic product candidates using a proprietary Lemna-based manufacturing platform  Learn more
	Bonovo Orthopedics Providing the latest orthopedic products to the Chinese healthcare community  Learn more
	Cerapedics Developing and commercializing products for the orthopedic bone substitutes market  Learn more
	Cerenis Therapeutics Discovering and developing breakthrough HDL-related therapies for the treatment of cardiovascular and metabolic diseases  Learn more
	Cerimon Pharmaceuticals Developing therapies for pain, inflammation & autoimmune disease  Learn more
	ChemoCentryx A drug discovery and development company focused on the immune system  Learn more
	Complete Genomics Revolutionizing the market for DNA sequencing  Learn more
	Crown Bioscience A pre-clinical CRO with leadership in translational oncology and cancer drug discovery partnerships  Learn more
	DFine Developing and marketing devices for vertebral compression fractures  Learn more
	Ecron Acunova Provides end-to-end services for clinical research, including Clinical Trial Management, Clinical Data Management, PK/PD services and Central Lab  Learn more
	Eddingpharm Commercializing a broad range of pharmaceutical products in high growth China markets  Learn more
	Enobia Developing therapeutics for the treatment of bone disorders  Learn more
	ForteBio, Inc. Developing analytical systems to provide rapid, real-time results for protein quantification and characterization of protein-protein interactions  Learn more
	Glaukos Transforming glaucoma therapy  Learn more
	Good Start Genetics Developing improved methods of pre-pregnancy testing that utilizes advanced gene capture and sequencing technologies  Learn more
	Igenica Discovering and developing breakthrough antibody-based therapeutics for the treatment of cancer  Learn more
	Inhibitex Developing therapies for infectious diseases, including shingles and hepatitis C  Learn more
	Insulet Developing novel medical devices for treatment of diabetes  Learn more
	Kalidex Pharmaceuticals Developing next-generation, broad-spectrum antibiotics for the treatment of serious infections  Learn more
	MacroGenics Developing novel immunotherapeutics across multiple diseases  Learn more
	MethylGene Developing novel and proprietary small molecule enzyme inhibitors for the treatment of cancer and infectious diseases.  Learn more
	NeurAxon Discovering and developing next generation pain therapeutics  Learn more
	NxStage Medical Commercializing products to significantly improve renal care  Learn more
	Pacira Pharmaceuticals Developing pain products which improve patient care through enhanced dosing and administration profiles  Learn more
	PharmAbcine Developing fully human therapeutic antibodies for the treatment of cancer  Learn more
	Pieris AG Discovering and developing Anticalins®, a novel class of targeted protein therapeutics  Learn more
	Realton Corporation Developing diode-pumped laser systems for the treatment of enlarged prostate  Learn more
	Receptos Discovering and developing new therapies through pioneering GPCR technology  Learn more
	Relypsa Discovering and developing novel non-absorbed polymeric drugs for important applications in cardiovascular and renal diseases  Learn more
	Response BioMedical Corp. Manufactures and markets rapid on-site diagnostic tests  Learn more
	Roka BioScience Commercializing novel nucleic acid testing methods for industrial applications  Learn more
	Selecta Biosciences Developing first-in-class integrated synthetic nanoparticle vaccines  Learn more
	Sientra, Inc. Developing products for the plastic surgery and aesthetics markets  Learn more
	Singulex Developing and commercializing the next generation of biomarker discovery and validation technologies  Learn more
	SMT Research and Development Ltd. Developing procedural tools and accessories for use during TAVI and other complex percutaneous structural heart procedures.  Learn more
	superDimension Providing minimally-invasive diagnosis and treatment of lung disease via endoscopic tools  Learn more
	Supernus Pharmaceuticals Leveraging unique drug delivery expertise to develop specialty pharmaceutical products  Learn more
	Vessix Vascular Developing novel radiofrequency balloon catheter technology  Learn more
	ViewRay Developing next generation radiotherapy technologies  Learn more